Time to Uveitis Control with Methotrexate and Mycophenolate Mofetil
- 1 June 2022
- journal article
- editorial
- Published by Elsevier BV in Ophthalmology
- Vol. 129 (6), 721-723
- https://doi.org/10.1016/j.ophtha.2022.01.020
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With UveitisJAMA, 2019
- Comparison Between Methotrexate and Mycophenolate Mofetil Monotherapy for the Control of Noninfectious Ocular Inflammatory DiseasesAmerican Journal of Ophthalmology, 2019
- Comparison of Antimetabolite Drugs as Corticosteroid-Sparing Therapy for Noninfectious Ocular InflammationOphthalmology, 2008
- Immunomodulatory Therapy in UveitisPublished by Springer Science and Business Media LLC ,2005
- Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International WorkshopAmerican Journal of Ophthalmology, 2005
- Uveitis: A Potentially Blinding DiseaseOphthalmologica, 2004
- Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panelAmerican Journal of Ophthalmology, 2000